Review



penicillin streptomycin p s  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    ATCC penicillin streptomycin p s
    Penicillin Streptomycin P S, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/Primary+Skeletal+Muscle+Growth+Kit/pmc13091133-72-33-30
    Average 94 stars, based on 30 article reviews
    penicillin streptomycin p s - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Recombinant ADAMTS-1 promotes muscle regeneration accompanied by downregulation of Notch signaling
    Article Snippet: Primary skeletal muscle cells were lysed in CelLytic M buffer (cat. no. C2978; MilliporeSigma) and all subsequent steps followed the same procedures as described for the in vivo western blot protocol. .. Primary skeletal muscle cells (cat. no. PCS-950-010; ATCC) were cultured in a complete expansion medium (cat. no. PCS-500-030; ATCC) using a primary skeletal muscle cell growth kit (cat. no. PCS-950-040; ATCC). .. Primary skeletal muscle cells were lysed in CelLytic M buffer (cat. no. C2978; MilliporeSigma) and all subsequent steps followed the same procedures as described for the in vivo western blot protocol.

    Article Title: Muscle-fiber-inspired nanofibrillar microbundles induce myogenic differentiation in human adipose-derived stem cells
    Article Snippet: .. HSkMCs (ATCC, Manassas, VA, USA) were cultured according to the manufacturer's recommendations in ATCC Mesenchymal Stem Cell Basal Medium (PCS-500-030, ATCC) supplemented with the Primary Skeletal Muscle Growth Kit (PCS-950-040, ATCC) and 1% penicillin–streptomycin (P/S), under standard culture conditions (37 °C, 5% CO 2 ). .. In parallel, hASCs (Lonza, Basel, Switzerland) were cultured in DMEM/F-12 (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal calf serum (FCS) and 1% P/S under the same conditions.

    Article Title: Muscle-fiber-inspired nanofibrillar microbundles induce myogenic differentiation in human adipose-derived stem cells
    Article Snippet: .. HSkMCs (ATCC, Manassas, VA, USA) were cultured according to the manufacturer's recommendations in ATCC Mesenchymal Stem Cell Basal Medium (PCS-500-030, ATCC) supplemented with the Primary Skeletal Muscle Growth Kit (PCS-950-040, ATCC) and 1% penicillin–streptomycin (P/S), under standard culture conditions (37 ◦C, 5% CO2). .. In parallel, hASCs (Lonza, Basel, Switzerland) were cultured in DMEM/F-12 (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal calf serum (FCS) and 1% P/S under the same conditions.

    Article Title: Targeting TOMM40 and TOMM22 to Rescue Statin-Impaired Mitochondrial Function, Dynamics, and Mitophagy in Skeletal Myotubes
    Article Snippet: .. For hSkMCs, cells were cultured in mesenchymal stem cell basal medium (PCS-500-030, ATCC, Manassas, VA, USA) supplemented with L-glutamine, 5 ng/mL rh EGF, 10 μM dexamethasone, 5 ng/mL rh FGF-b, 25 μg/mL rh insulin, 4% FBS (PCS-950-040, ATCC, Manassas, VA, USA), and penicillin-streptomycin (Gibco). .. At 24–96 h after passaging, hSkMCs were differentiated into myotubes using a skeletal muscle differentiation tool (PCS-950-050, ATCC, Manassas, VA, USA) for 2 days before experimentation.

    other:

    Article Title: Novel heterosteroids induce anabolic effects in human skeletal muscle cells: An integrated analysis of anabolic and catabolic signaling pathways.
    Article Snippet: The aim of this study was to investigate the anabolic potential of novel heterosteroids in human skeletal muscle cells.. A library of new heterosteroids was synthesized by selectively modifying the A and B rings of steroidal sapogenins (diosgenin, sarsasapogenin, and hecogenin), with six library members (S1, D3, D5, D7, D8 and D13) subsequently tested in vitro.. Compound selection was based on computational modeling intracellular signaling pathways regulating muscle hypertrophy and atrophy, coupled with pharmacological potential evaluation using cheminformatics tools.

    Encapsulation:

    Article Title: CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses
    Article Snippet: .. The encapsulation efficiency (EE%) was 442 calculated as 443 total mRNA−unencapsulated mRNAtotal mRNA × 100%. (1) 444 Human skeletal muscle culture 445 Primary human skeletal muscle cells (ATCC PCS-950-010) were first expanded in complete 446 growth media prepared by adding one Primary Skeletal Cell Muscle Growth Kit (ATCC PCS-950-447 040) to one bottle of Mesenchymal Stem Cell Basal Medium (ATCC PCS-500-030). .. The sizes of mRNA LNPs were measured 435 by dynamic light scattering (DLS) analysis with Malvern Zetasizer.



    Similar Products

    99
    ATCC normal human dermal fibroblast
    Normal Human Dermal Fibroblast, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/Primary+Dermal+Fibroblast%3B+Normal%2C+Human%2C+Adult/pmc13755844-329-37-42
    Average 99 stars, based on 1 article reviews
    normal human dermal fibroblast - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    90
    DePuy Synthes the cemented attune™ primary knee system®
    The Cemented Attune™ Primary Knee System®, supplied by DePuy Synthes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/attune+knee+system/nct06074744-6-10-14
    Average 90 stars, based on 1 article reviews
    the cemented attune™ primary knee system® - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    99
    ATCC human umbilical vein endothelial cells huvecs
    The physiochemical characterization of SαV‐DAb. (a) Flow cytometry confirming SIRPα overexpression. (b) Fluorescence imaging validating the SIRPα overexpression (Scale bar = 20 µm). (c) Western blot detecting SIRPα in both parent cells and nanovesicles. GAPDH and Na + /K + ‐ATPase were used as loading references for cell lysates and nanovesicle samples, respectively. (d) Representative transmission electron microscopy (TEM) images of the nanovesicles (Scale bar = 100 nm). (e) Coomassie Brilliant Blue staining demonstrating successful antibody (Ab) conjugation. Arrowheads indicate Ab heavy chains. (f) Simultaneous dual‐Ab modification visualized using fluorescence‐labeled antibodies (scale bar = 20 µm). (g, h) The mean diameter of all types of nanovesicles (g) and the size distribution of SαV‐DAb (h). The size distribution was determined from three batches of prepared SαV‐DAb to reflect intra‐batch and inter‐batch uniformity. Error bars (red) indicate ±1 standard error of the mean (SEM). (i) Zeta potential for SαVs with different antibody modification. (j, k) Stability assessment of SαV and SαV‐DAb incubated in 10% FBS for one week, monitored through changes in diameter (j) and zeta potential (k). (l) Cytotoxicity evaluation of engineered SαV carrying different antibody toward cardiomyoblasts (H9C2) and human umbilical vein <t>endothelial</t> cells <t>(HUVECs).</t>
    Human Umbilical Vein Endothelial Cells Huvecs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/Primary+Umbilical+Vein+Endothelial+Cells%3B+Normal%2C+Human/pmc13771586-157-6-15
    Average 99 stars, based on 1 article reviews
    human umbilical vein endothelial cells huvecs - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology ahr primary antibody
    The physiochemical characterization of SαV‐DAb. (a) Flow cytometry confirming SIRPα overexpression. (b) Fluorescence imaging validating the SIRPα overexpression (Scale bar = 20 µm). (c) Western blot detecting SIRPα in both parent cells and nanovesicles. GAPDH and Na + /K + ‐ATPase were used as loading references for cell lysates and nanovesicle samples, respectively. (d) Representative transmission electron microscopy (TEM) images of the nanovesicles (Scale bar = 100 nm). (e) Coomassie Brilliant Blue staining demonstrating successful antibody (Ab) conjugation. Arrowheads indicate Ab heavy chains. (f) Simultaneous dual‐Ab modification visualized using fluorescence‐labeled antibodies (scale bar = 20 µm). (g, h) The mean diameter of all types of nanovesicles (g) and the size distribution of SαV‐DAb (h). The size distribution was determined from three batches of prepared SαV‐DAb to reflect intra‐batch and inter‐batch uniformity. Error bars (red) indicate ±1 standard error of the mean (SEM). (i) Zeta potential for SαVs with different antibody modification. (j, k) Stability assessment of SαV and SαV‐DAb incubated in 10% FBS for one week, monitored through changes in diameter (j) and zeta potential (k). (l) Cytotoxicity evaluation of engineered SαV carrying different antibody toward cardiomyoblasts (H9C2) and human umbilical vein <t>endothelial</t> cells <t>(HUVECs).</t>
    Ahr Primary Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/AHR+Rabbit+pAb/pmc13771667-390-29-34
    Average 94 stars, based on 1 article reviews
    ahr primary antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    ATCC human peripheral blood mononuclear cells
    The physiochemical characterization of SαV‐DAb. (a) Flow cytometry confirming SIRPα overexpression. (b) Fluorescence imaging validating the SIRPα overexpression (Scale bar = 20 µm). (c) Western blot detecting SIRPα in both parent cells and nanovesicles. GAPDH and Na + /K + ‐ATPase were used as loading references for cell lysates and nanovesicle samples, respectively. (d) Representative transmission electron microscopy (TEM) images of the nanovesicles (Scale bar = 100 nm). (e) Coomassie Brilliant Blue staining demonstrating successful antibody (Ab) conjugation. Arrowheads indicate Ab heavy chains. (f) Simultaneous dual‐Ab modification visualized using fluorescence‐labeled antibodies (scale bar = 20 µm). (g, h) The mean diameter of all types of nanovesicles (g) and the size distribution of SαV‐DAb (h). The size distribution was determined from three batches of prepared SαV‐DAb to reflect intra‐batch and inter‐batch uniformity. Error bars (red) indicate ±1 standard error of the mean (SEM). (i) Zeta potential for SαVs with different antibody modification. (j, k) Stability assessment of SαV and SαV‐DAb incubated in 10% FBS for one week, monitored through changes in diameter (j) and zeta potential (k). (l) Cytotoxicity evaluation of engineered SαV carrying different antibody toward cardiomyoblasts (H9C2) and human umbilical vein <t>endothelial</t> cells <t>(HUVECs).</t>
    Human Peripheral Blood Mononuclear Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/Primary+Peripheral+Blood+Mononuclear+Cells+(PBMC)%2C+Normal%2C+Human/pmc13770899-72-7-14
    Average 99 stars, based on 1 article reviews
    human peripheral blood mononuclear cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    93
    Proteintech primary antibodies fstl1
    The physiochemical characterization of SαV‐DAb. (a) Flow cytometry confirming SIRPα overexpression. (b) Fluorescence imaging validating the SIRPα overexpression (Scale bar = 20 µm). (c) Western blot detecting SIRPα in both parent cells and nanovesicles. GAPDH and Na + /K + ‐ATPase were used as loading references for cell lysates and nanovesicle samples, respectively. (d) Representative transmission electron microscopy (TEM) images of the nanovesicles (Scale bar = 100 nm). (e) Coomassie Brilliant Blue staining demonstrating successful antibody (Ab) conjugation. Arrowheads indicate Ab heavy chains. (f) Simultaneous dual‐Ab modification visualized using fluorescence‐labeled antibodies (scale bar = 20 µm). (g, h) The mean diameter of all types of nanovesicles (g) and the size distribution of SαV‐DAb (h). The size distribution was determined from three batches of prepared SαV‐DAb to reflect intra‐batch and inter‐batch uniformity. Error bars (red) indicate ±1 standard error of the mean (SEM). (i) Zeta potential for SαVs with different antibody modification. (j, k) Stability assessment of SαV and SαV‐DAb incubated in 10% FBS for one week, monitored through changes in diameter (j) and zeta potential (k). (l) Cytotoxicity evaluation of engineered SαV carrying different antibody toward cardiomyoblasts (H9C2) and human umbilical vein <t>endothelial</t> cells <t>(HUVECs).</t>
    Primary Antibodies Fstl1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/FSTL1+Antibody/pm43000092-69-3-8
    Average 93 stars, based on 1 article reviews
    primary antibodies fstl1 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    97
    ATCC human epithelial cell line
    The physiochemical characterization of SαV‐DAb. (a) Flow cytometry confirming SIRPα overexpression. (b) Fluorescence imaging validating the SIRPα overexpression (Scale bar = 20 µm). (c) Western blot detecting SIRPα in both parent cells and nanovesicles. GAPDH and Na + /K + ‐ATPase were used as loading references for cell lysates and nanovesicle samples, respectively. (d) Representative transmission electron microscopy (TEM) images of the nanovesicles (Scale bar = 100 nm). (e) Coomassie Brilliant Blue staining demonstrating successful antibody (Ab) conjugation. Arrowheads indicate Ab heavy chains. (f) Simultaneous dual‐Ab modification visualized using fluorescence‐labeled antibodies (scale bar = 20 µm). (g, h) The mean diameter of all types of nanovesicles (g) and the size distribution of SαV‐DAb (h). The size distribution was determined from three batches of prepared SαV‐DAb to reflect intra‐batch and inter‐batch uniformity. Error bars (red) indicate ±1 standard error of the mean (SEM). (i) Zeta potential for SαVs with different antibody modification. (j, k) Stability assessment of SαV and SαV‐DAb incubated in 10% FBS for one week, monitored through changes in diameter (j) and zeta potential (k). (l) Cytotoxicity evaluation of engineered SαV carrying different antibody toward cardiomyoblasts (H9C2) and human umbilical vein <t>endothelial</t> cells <t>(HUVECs).</t>
    Human Epithelial Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/Primary+Small+Airway+Epithelial+Cells%3B+Normal%2C+Human/pm43027366-93-4-18
    Average 97 stars, based on 1 article reviews
    human epithelial cell line - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    95
    ABclonal Biotechnology primary rabbit polyclonal anti lc3a lc3b antibody
    The physiochemical characterization of SαV‐DAb. (a) Flow cytometry confirming SIRPα overexpression. (b) Fluorescence imaging validating the SIRPα overexpression (Scale bar = 20 µm). (c) Western blot detecting SIRPα in both parent cells and nanovesicles. GAPDH and Na + /K + ‐ATPase were used as loading references for cell lysates and nanovesicle samples, respectively. (d) Representative transmission electron microscopy (TEM) images of the nanovesicles (Scale bar = 100 nm). (e) Coomassie Brilliant Blue staining demonstrating successful antibody (Ab) conjugation. Arrowheads indicate Ab heavy chains. (f) Simultaneous dual‐Ab modification visualized using fluorescence‐labeled antibodies (scale bar = 20 µm). (g, h) The mean diameter of all types of nanovesicles (g) and the size distribution of SαV‐DAb (h). The size distribution was determined from three batches of prepared SαV‐DAb to reflect intra‐batch and inter‐batch uniformity. Error bars (red) indicate ±1 standard error of the mean (SEM). (i) Zeta potential for SαVs with different antibody modification. (j, k) Stability assessment of SαV and SαV‐DAb incubated in 10% FBS for one week, monitored through changes in diameter (j) and zeta potential (k). (l) Cytotoxicity evaluation of engineered SαV carrying different antibody toward cardiomyoblasts (H9C2) and human umbilical vein <t>endothelial</t> cells <t>(HUVECs).</t>
    Primary Rabbit Polyclonal Anti Lc3a Lc3b Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/LC3A%2FLC3B+Rabbit+pAb/pmc13760597-68-0-5
    Average 95 stars, based on 1 article reviews
    primary rabbit polyclonal anti lc3a lc3b antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    99
    ATCC pbmc derived cd14 monocytes
    The physiochemical characterization of SαV‐DAb. (a) Flow cytometry confirming SIRPα overexpression. (b) Fluorescence imaging validating the SIRPα overexpression (Scale bar = 20 µm). (c) Western blot detecting SIRPα in both parent cells and nanovesicles. GAPDH and Na + /K + ‐ATPase were used as loading references for cell lysates and nanovesicle samples, respectively. (d) Representative transmission electron microscopy (TEM) images of the nanovesicles (Scale bar = 100 nm). (e) Coomassie Brilliant Blue staining demonstrating successful antibody (Ab) conjugation. Arrowheads indicate Ab heavy chains. (f) Simultaneous dual‐Ab modification visualized using fluorescence‐labeled antibodies (scale bar = 20 µm). (g, h) The mean diameter of all types of nanovesicles (g) and the size distribution of SαV‐DAb (h). The size distribution was determined from three batches of prepared SαV‐DAb to reflect intra‐batch and inter‐batch uniformity. Error bars (red) indicate ±1 standard error of the mean (SEM). (i) Zeta potential for SαVs with different antibody modification. (j, k) Stability assessment of SαV and SαV‐DAb incubated in 10% FBS for one week, monitored through changes in diameter (j) and zeta potential (k). (l) Cytotoxicity evaluation of engineered SαV carrying different antibody toward cardiomyoblasts (H9C2) and human umbilical vein <t>endothelial</t> cells <t>(HUVECs).</t>
    Pbmc Derived Cd14 Monocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/Primary+Peripheral+Blood+CD14%2B+Monocytes%2C+Normal%2C+Human/pmc13763876-254-9-13
    Average 99 stars, based on 1 article reviews
    pbmc derived cd14 monocytes - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti human atgl primary antibody
    RBP1 silencing induces <t>ATGL-dependent</t> lipid mobilization. A Representative immunoblot of LC3 protein levels in control and siRBP1 LECs (n = 3). Densitometric quantification of protein levels (normalized to GAPDH as loading control and expressed relative to the control condition) is shown beneath the blot. B , C Representative images of <t>BODIPY-palmitate</t> 493/503 (green) staining ( B ) and quantification of lipid droplet density per cell ( C ) in control and siRBP1 LECs. Nuclei were counterstained with DAPI (blue) (n = 3). D Representative immunoblot of ATG5 protein levels in siRBP1 versus control LECs following treatment with chloroquine (CQ) (n = 3). Densitometric quantification of protein levels (normalized to vinculin as loading control and expressed relative to the control condition) is shown beneath the blot. E LC–MS measurements of free fatty acid levels in siRBP1 versus control LECs (n = 4). F , G Representative immunostainings of BODIPY-Palmitate 493/503 (green) and ATGL (red) ( F ) and quantification of ATGL intensity ( G ) in the surface of lipid droplets in control versus siRBP1 LECs. Nuclei were counterstained with DAPI (blue) (n = 3). H–J Representative immunostainings of BODIPY-Palmitate (green) ( H ) and quantification of the number of lipid droplets ( I ) or total lipid droplet area per cell ( J ) in control versus siRBP1 LECs treated with NG-497 (or DMSO as a vehicle control). Nuclei were counterstained with DAPI (n = 3). *P < 0.05 by two-tailed Student’s t-test ( C , G , I , J ) and two-tailed one-sample t-test ( A , D , E ). Scale bars represent 30 µm in B , F , H
    Rabbit Anti Human Atgl Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary/ATGL+Antibody/pmc13756975-310-13-20
    Average 96 stars, based on 1 article reviews
    rabbit anti human atgl primary antibody - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    The physiochemical characterization of SαV‐DAb. (a) Flow cytometry confirming SIRPα overexpression. (b) Fluorescence imaging validating the SIRPα overexpression (Scale bar = 20 µm). (c) Western blot detecting SIRPα in both parent cells and nanovesicles. GAPDH and Na + /K + ‐ATPase were used as loading references for cell lysates and nanovesicle samples, respectively. (d) Representative transmission electron microscopy (TEM) images of the nanovesicles (Scale bar = 100 nm). (e) Coomassie Brilliant Blue staining demonstrating successful antibody (Ab) conjugation. Arrowheads indicate Ab heavy chains. (f) Simultaneous dual‐Ab modification visualized using fluorescence‐labeled antibodies (scale bar = 20 µm). (g, h) The mean diameter of all types of nanovesicles (g) and the size distribution of SαV‐DAb (h). The size distribution was determined from three batches of prepared SαV‐DAb to reflect intra‐batch and inter‐batch uniformity. Error bars (red) indicate ±1 standard error of the mean (SEM). (i) Zeta potential for SαVs with different antibody modification. (j, k) Stability assessment of SαV and SαV‐DAb incubated in 10% FBS for one week, monitored through changes in diameter (j) and zeta potential (k). (l) Cytotoxicity evaluation of engineered SαV carrying different antibody toward cardiomyoblasts (H9C2) and human umbilical vein endothelial cells (HUVECs).

    Journal: Advanced Science

    Article Title: Complementary Cardioprotection and Efferocytosis by Circulating Vesicle Recruitment and SIRPα Blockade after Myocardial Ischemia/Reperfusion

    doi: 10.1002/advs.78697

    Figure Lengend Snippet: The physiochemical characterization of SαV‐DAb. (a) Flow cytometry confirming SIRPα overexpression. (b) Fluorescence imaging validating the SIRPα overexpression (Scale bar = 20 µm). (c) Western blot detecting SIRPα in both parent cells and nanovesicles. GAPDH and Na + /K + ‐ATPase were used as loading references for cell lysates and nanovesicle samples, respectively. (d) Representative transmission electron microscopy (TEM) images of the nanovesicles (Scale bar = 100 nm). (e) Coomassie Brilliant Blue staining demonstrating successful antibody (Ab) conjugation. Arrowheads indicate Ab heavy chains. (f) Simultaneous dual‐Ab modification visualized using fluorescence‐labeled antibodies (scale bar = 20 µm). (g, h) The mean diameter of all types of nanovesicles (g) and the size distribution of SαV‐DAb (h). The size distribution was determined from three batches of prepared SαV‐DAb to reflect intra‐batch and inter‐batch uniformity. Error bars (red) indicate ±1 standard error of the mean (SEM). (i) Zeta potential for SαVs with different antibody modification. (j, k) Stability assessment of SαV and SαV‐DAb incubated in 10% FBS for one week, monitored through changes in diameter (j) and zeta potential (k). (l) Cytotoxicity evaluation of engineered SαV carrying different antibody toward cardiomyoblasts (H9C2) and human umbilical vein endothelial cells (HUVECs).

    Article Snippet: Briefly, rat ventricular cardiomyoblasts (H9C2) and human umbilical vein endothelial cells (HUVECs) were obtained from ATCC.

    Techniques: Flow Cytometry, Over Expression, Fluorescence, Imaging, Western Blot, Transmission Assay, Electron Microscopy, Staining, Conjugation Assay, Modification, Labeling, Zeta Potential Analyzer, Stability, Incubation

    RBP1 silencing induces ATGL-dependent lipid mobilization. A Representative immunoblot of LC3 protein levels in control and siRBP1 LECs (n = 3). Densitometric quantification of protein levels (normalized to GAPDH as loading control and expressed relative to the control condition) is shown beneath the blot. B , C Representative images of BODIPY-palmitate 493/503 (green) staining ( B ) and quantification of lipid droplet density per cell ( C ) in control and siRBP1 LECs. Nuclei were counterstained with DAPI (blue) (n = 3). D Representative immunoblot of ATG5 protein levels in siRBP1 versus control LECs following treatment with chloroquine (CQ) (n = 3). Densitometric quantification of protein levels (normalized to vinculin as loading control and expressed relative to the control condition) is shown beneath the blot. E LC–MS measurements of free fatty acid levels in siRBP1 versus control LECs (n = 4). F , G Representative immunostainings of BODIPY-Palmitate 493/503 (green) and ATGL (red) ( F ) and quantification of ATGL intensity ( G ) in the surface of lipid droplets in control versus siRBP1 LECs. Nuclei were counterstained with DAPI (blue) (n = 3). H–J Representative immunostainings of BODIPY-Palmitate (green) ( H ) and quantification of the number of lipid droplets ( I ) or total lipid droplet area per cell ( J ) in control versus siRBP1 LECs treated with NG-497 (or DMSO as a vehicle control). Nuclei were counterstained with DAPI (n = 3). *P < 0.05 by two-tailed Student’s t-test ( C , G , I , J ) and two-tailed one-sample t-test ( A , D , E ). Scale bars represent 30 µm in B , F , H

    Journal: Experimental Hematology & Oncology

    Article Title: RBP1-driven retinol metabolism in tumor-associated lymphatic endothelial cells orchestrates triple-negative breast cancer progression and lymphatic metastasis

    doi: 10.1186/s40164-026-00842-9

    Figure Lengend Snippet: RBP1 silencing induces ATGL-dependent lipid mobilization. A Representative immunoblot of LC3 protein levels in control and siRBP1 LECs (n = 3). Densitometric quantification of protein levels (normalized to GAPDH as loading control and expressed relative to the control condition) is shown beneath the blot. B , C Representative images of BODIPY-palmitate 493/503 (green) staining ( B ) and quantification of lipid droplet density per cell ( C ) in control and siRBP1 LECs. Nuclei were counterstained with DAPI (blue) (n = 3). D Representative immunoblot of ATG5 protein levels in siRBP1 versus control LECs following treatment with chloroquine (CQ) (n = 3). Densitometric quantification of protein levels (normalized to vinculin as loading control and expressed relative to the control condition) is shown beneath the blot. E LC–MS measurements of free fatty acid levels in siRBP1 versus control LECs (n = 4). F , G Representative immunostainings of BODIPY-Palmitate 493/503 (green) and ATGL (red) ( F ) and quantification of ATGL intensity ( G ) in the surface of lipid droplets in control versus siRBP1 LECs. Nuclei were counterstained with DAPI (blue) (n = 3). H–J Representative immunostainings of BODIPY-Palmitate (green) ( H ) and quantification of the number of lipid droplets ( I ) or total lipid droplet area per cell ( J ) in control versus siRBP1 LECs treated with NG-497 (or DMSO as a vehicle control). Nuclei were counterstained with DAPI (n = 3). *P < 0.05 by two-tailed Student’s t-test ( C , G , I , J ) and two-tailed one-sample t-test ( A , D , E ). Scale bars represent 30 µm in B , F , H

    Article Snippet: For double ATGL and BODIPY-Palmitate immunostainings, coverslips were permeabilized, blocked and incubated with rabbit anti-human ATGL primary antibody [1:200] (55190-1-AP, Proteintech) overnight at 4 oC.

    Techniques: Western Blot, Control, Staining, Liquid Chromatography with Mass Spectroscopy, Two Tailed Test